figshare
Browse
yhem_a_1355421_sm1669.xlsx (10.74 kB)

Immunophenotypic analysis of adult patients with T-cell lymphoblastic lymphoma treated with hyper-CVAD

Download (10.74 kB)
dataset
posted on 2017-08-05, 05:33 authored by Harumi Kato, Kazuhito Yamamoto, Takeshi Kodaira, Yusuke Higuchi, Hideyuki Yamamoto, Toko Saito, Hirofumi Taji, Yasushi Yatabe, Shigeo Nakamura, Tomohiro Kinoshita

Objectives: Immunophenotype is an important prognostic factor for childhood and adult T-cell acute lymphoblastic leukemia. However, immunophenotypic data from adult patients with T-cell lymphoblastic lymphoma (T-LBL) are scarcely available.

Methods: Subjects were unselected adult patients with T-LBL who were treated with intensive chemotherapy. Immunophenotyping of tumor cells was performed according to standard techniques.

Results: A total of eight patients with a median age of 31 years were analyzed who received hyper-CVAD treatment for LBL. Immunophenotypic analysis showed that the most common tumor type was cortical T-cell type [early T (n = 2), cortical T (n = 4), and medullary T (n = 2)]. Two patients diagnosed with early T-cell type had early disease progression.

Conclusions: Assessment of T-cell differentiation stages in malignant T lymphoblasts would be important in choosing treatment strategies for adult patients with T-LBL.

Funding

This work was supported in part by the National Cancer Center Research and Development Fund (23-A-16, 23-A-17, 26-A-4), Health and Labour Sciences Research Grant for Clinical Cancer Research (19-27, 22-29) from the Ministry of Health, Labour and Welfare, a Health and Labour Sciences Research Grant (H27-Cancer Control-Ippan-005), a grand from the Japan Agency for Medical Research and Development (AMED) (17ck0106349h0001), and a Grant-in-Aid for Aichi Cancer Center Project Research. K.Y. has received research funding from Kyowa Hakko Kirin.

History